Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nivalis Therapeutics, Inc. | 200,000 | reported | 02 Oct 2023 | tx 1+200,000 |
| Aridis Pharmaceuticals, Inc. | 81,094 | reported | 05 Dec 2018 | tx 2+50,000 |
| RIGEL PHARMACEUTICALS INC | 72,459 | reported | 02 Feb 2023 | tx 9+670,000−5,389 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Oct 2023 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 02 Feb 2023 | SALE | RIGEL PHARMACEUTICALS INC | 5,389 | 1.66 USD | |
| 26 Jan 2023 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 50,000 | 0.00 USD | deriv |
| 28 Dec 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 50,000 | 0.00 USD | deriv |
| 24 Jan 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 50,000 | 0.00 USD | |
| 24 Jan 2022 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 100,000 | 0.00 USD | deriv |
| 04 Nov 2021 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 37,500 | 0.00 USD | deriv |
| 27 Jan 2021 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 125,000 | 0.00 USD | deriv |
| 27 Jan 2021 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 37,500 | 0.00 USD | deriv |
| 18 Nov 2019 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 220,000 | 0.00 USD | deriv |
| 05 Dec 2018 | GRANT_AWARD | Aridis Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |